November 2, 2021, 6:25 p.m. (ChST)
COVID-19 Updates: Preliminary Test Results: 35 New Cases, 58 Hospitalized;
Monoclonal Antibody Therapy Treatment Continues
58 Hospitalized for COVID-19
SPECIAL NOTE: Based on today's data, if we were to compare two (2) hypothetical populations of 100,000 people each, vaccinated versus unvaccinated, there would be 25 vaccinated people hospitalized for COVID-19 compared to 210 unvaccinated people hospitalized for COVID- 19. The risk of being hospitalized for COVID-19 is about 8 times higher for the unvaccinated as compared to the vaccinated.
Preliminary COVID-19 Test Results: 35 New Cases
Today, the Department of Public Health and Social Services (DPHSS) reported a preliminary case count of 35 new cases of COVID-19 from 472 specimens analyzed on November 1. Additional results are pending analysis and submission from other clinics and will be reported on Wednesday, November 3. To date, there have been a total of 18,321 officially reported cases, 242 deaths, 2,347 cases in active isolation, and 15,732 not in active isolation. As of November 1, CAR Score is 15.7.
Monoclonal Antibody Therapy Treatment Continues
DPHSS, in partnership with the Mayors’ Council of Guam and the Guam National Guard, continues to offer outpatient monoclonal antibody (mAb) therapy at the Mangilao Senior Citizens Center in Mangilao. Patients may receive mAb therapy if they meet the eligibility criteria through a referral from their private physician, a COVID-19 community test site, or a hospital. A Pre-Screening Assessment has been developed to guide individuals who may be eligible for mAb treatment. To schedule an appointment, call 671-998-4627 from 8 a.m. to 4 p.m. or 671-734-9203 from 4 p.m. to 8 p.m. Monday through Saturday. For more information, CLICK HERE.